Brief: Aeon Biopharma Announces $15 Million Financing Transaction And Termination Of Forward Purchase Agreements
19/03/2024 22:27
March 19 (Reuters) - Aeon Biopharma Inc AEON.A :
* AEON BIOPHARMA ANNOUNCES $15 MILLION FINANCING TRANSACTION
AND
TERMINATION OF FORWARD PURCHASE AGREEMENTS
* AEON BIOPHARMA INC - TO EXPAND BOARD WITH APPOINTMENT OF
CANDIDATE SELECTED BY ITS STRATEGIC PARTNER FOLLOWING FULL
FUNDING OF TRANSACTION
* AEON - PROCEEDS FROM PRIVATE PLACEMENT WILL BE USED TO
SUPPORT
LATE-STAGE CLINICAL DEVELOPMENT OF ABP-450 AND FOR GENERAL
WORKING CAPITAL PURPOSES
Source text for Eikon: ID:nGNX5bS0zP
Further company coverage: AEON.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition